Refusal to market new drugs
Other Names: Refusal to test new drugs
Denial of potential health aids
Stopping development of medical cures
Nature: New drugs that can counteract tuberculosis are ready for testing, but the American pharmaceutical industry refuses to pay to test and market them due to the costs involved, which it claims are $200 million US. It says that the US market for the drug is too small to recover its costs, entirely ignoring about 1.75 billion tubercular people outside its borders who need the drugs. There is no American or global agency that can legally force the pharmaceutical companies to sell their products.
Counter Claim: Critics state that $200 million US is too high an estimate of testing and marketing costs.
Problem Type: G: Very specific problems
Date of last update 27.04.2000 – 00:00 CEST